(Q36691091)

15 August 2017

1 reference

title

Regulation of immune tolerance by anti-inflammatory neuropeptides (English)

1 reference

15 August 2017

0 references

2

Alejo Chorny

1 reference

15 August 2017

Elena Gonzalez-Rey

1

1 reference

15 August 2017

Mario Delgado

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Nature Reviews Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

52-63

1 reference

Regulatory CD4+ T cells and the control of autoimmune disease.

15 August 2017

cites work

1 reference

Regulatory T cells in transplantation tolerance

31 March 2020

1 reference

Polypeptide with Broad Biological Activity: Isolation from Small Intestine

31 March 2020

1 reference

Vasoactive Intestinal Polypeptide: Abundant Immunoreactivity in Neural Cell Lines and Normal Nervous Tissue

31 March 2020

1 reference

Melanocortin receptors: their functions and regulation by physiological agonists and antagonists

31 March 2020

1 reference

Vasoactive intestinal polypeptide (VIP) innervation of rat spleen, thymus, and lymph nodes

31 March 2020

1 reference

Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?

31 March 2020

1 reference

Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone

31 March 2020

1 reference

The significance of vasoactive intestinal peptide in immunomodulation

31 March 2020

1 reference

MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions

31 March 2020

1 reference

The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro

31 March 2020

1 reference

Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R

31 March 2020

1 reference

Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway

31 March 2020

1 reference

In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH)

31 March 2020

1 reference

Innate immunity: the virtues of a nonclonal system of recognition

31 March 2020

1 reference

Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH.

31 March 2020

1 reference

Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia.

31 March 2020

1 reference

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells

31 March 2020

1 reference

Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subject

31 March 2020

1 reference

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages

31 March 2020

1 reference

Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo

31 March 2020

1 reference

New insights into the functions of alpha-MSH and related peptides in the immune system

31 March 2020

1 reference

VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells

31 March 2020

1 reference

Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.

31 March 2020

1 reference

alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages

31 March 2020

1 reference

Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide

31 March 2020

1 reference

Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor

31 March 2020

1 reference

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

31 March 2020

1 reference

Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice

31 March 2020

1 reference

B7-2 (CD86) is essential for the development of IL-4-producing T cells

31 March 2020

1 reference

VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.

31 March 2020

1 reference

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells

31 March 2020

1 reference

c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide

31 March 2020

1 reference

CD4+ CD25+ suppressor T cells: more questions than answers

31 March 2020

1 reference

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

31 March 2020

1 reference

Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.

31 March 2020

1 reference

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

31 March 2020

1 reference

Dendritic cells: emerging pharmacological targets of immunosuppressive drugs

31 March 2020

1 reference

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

31 March 2020

1 reference

The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells

31 March 2020

1 reference

Localization and physiological roles of urocortin

31 March 2020

1 reference

The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications

31 March 2020

1 reference

Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids

31 March 2020

1 reference

Modulation of the inflammatory response by corticotropin-releasing factor

31 March 2020

1 reference

Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice

31 March 2020

1 reference

Corticotropin-releasing hormone regulates IL-6 expression during inflammation

31 March 2020

1 reference

Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum

31 March 2020

1 reference

Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response

31 March 2020

1 reference

Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease

31 March 2020

1 reference

Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin

31 March 2020

1 reference

Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2

31 March 2020

1 reference

Urocortin in human gastric mucosa: relationship to inflammatory activity

31 March 2020

1 reference

International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands

31 March 2020

1 reference

Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response

31 March 2020

1 reference

Production of adrenomedullin in macrophage cell line and peritoneal macrophage

31 March 2020

1 reference

Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line

31 March 2020

1 reference

Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock

31 March 2020

1 reference

Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells

31 March 2020

1 reference

Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells

31 March 2020

1 reference

Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and os

31 March 2020

1 reference

International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors

31 March 2020

1 reference

Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis

31 March 2020

1 reference

Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions

31 March 2020

1 reference

Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system

31 March 2020

1 reference

Vasoactive Intestinal Polypeptide and Somatostatin in Leucocytes

31 March 2020

1 reference

Peptides as regulators of the immune system: emphasis on somatostatin

31 March 2020

1 reference

Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

31 March 2020

1 reference

Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia.

31 March 2020

1 reference

Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland

31 March 2020

1 reference

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

31 March 2020

1 reference

Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors

31 March 2020

1 reference

alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways.

31 March 2020

1 reference

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

31 March 2020

1 reference

The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.

31 March 2020

1 reference

Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation

31 March 2020

1 reference

Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock

31 March 2020

1 reference

In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation.

31 March 2020

1 reference

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

31 March 2020

1 reference

The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats

31 March 2020

1 reference

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

31 March 2020

1 reference

alpha-MSH modulates experimental inflammatory bowel disease

31 March 2020

1 reference

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses

31 March 2020

1 reference

Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide

31 March 2020

1 reference

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse

31 March 2020

1 reference

Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response

31 March 2020

1 reference

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

31 March 2020

1 reference

The immune system as the sixth sense.

31 March 2020

1 reference

VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease

31 March 2020

1 reference

Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice.

31 March 2020

1 reference

Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.

31 March 2020

1 reference

Proopiomelanocortin and the immune-neuroendocrine connection

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRI1984

1 reference

Dimensions Publication ID

15 August 2017

1014823005

0 references

1 reference